SLC2A1, solute carrier family 2 member 1, 6513

N. diseases: 687; N. variants: 76
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.320 AlteredExpression disease BEFREE GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer. 28542798 2018
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.320 Biomarker disease CTD_human Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells. 20138251 2010
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.320 AlteredExpression disease BEFREE The aim of the present study was to analyze the expression of different GLUT isoforms (GLUT1-4) and to investigate whether alterations in their expression pattern accompany the malignant transformation and progression of ovarian cancer. 15331928 2004
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.320 AlteredExpression disease LHGDN In contrast, GLUT1 expression was moderate in borderline tumors and weak to negative in all benign ovarian neoplasms. 15331928 2004